159 related articles for article (PubMed ID: 19435786)
1. Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
Zhang X; Liang SX; Jia L; Chen N; Fadare O; Schwartz PE; Kong B; Zheng W
Am J Pathol; 2009 Jun; 174(6):2000-6. PubMed ID: 19435786
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP
Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662
[TBL] [Abstract][Full Text] [Related]
3. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 expression in endometrial serous carcinomas and its precancers.
Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
[TBL] [Abstract][Full Text] [Related]
5. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
Jarboe EA; Miron A; Carlson JW; Hirsch MS; Kindelberger D; Mutter GL; Crum CP; Nucci MR
Int J Gynecol Pathol; 2009 Jul; 28(4):308-15. PubMed ID: 19483636
[TBL] [Abstract][Full Text] [Related]
6. Significance of p53 expression in background endometrium in endometrial carcinoma.
Nguyen TT; Hachisuga T; Urabe R; Kurita T; Kagami S; Kawagoe T; Shimajiri S; Nabeshima K
Virchows Arch; 2015 Jun; 466(6):695-702. PubMed ID: 25788166
[TBL] [Abstract][Full Text] [Related]
7. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
Egan JA; Ionescu MC; Eapen E; Jones JG; Marshall DS
Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
[TBL] [Abstract][Full Text] [Related]
9. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
[TBL] [Abstract][Full Text] [Related]
10. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
[TBL] [Abstract][Full Text] [Related]
11. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
[TBL] [Abstract][Full Text] [Related]
12. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
[TBL] [Abstract][Full Text] [Related]
13. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
Trahan S; Têtu B; Raymond PE
Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
[TBL] [Abstract][Full Text] [Related]
14. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.
Jia L; Yuan Z; Wang Y; Cragun JM; Kong B; Zheng W
Mod Pathol; 2015 Jan; 28(1):118-27. PubMed ID: 24925054
[TBL] [Abstract][Full Text] [Related]
15. Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
Brett MA; Atenafu EG; Singh N; Ghatage P; Clarke BA; Nelson GS; Bernardini MQ; Köbel M
Int J Gynecol Pathol; 2021 Mar; 40(2):116-123. PubMed ID: 32265358
[TBL] [Abstract][Full Text] [Related]
16. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
17. Precursors of endometrial clear cell carcinoma.
Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
[TBL] [Abstract][Full Text] [Related]
18. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
[TBL] [Abstract][Full Text] [Related]
19. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
20. Stromal p16 expression is significantly increased in endometrial carcinoma.
Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
